Digital PCR strategies in the development and analysis of molecular biomarkers for personalized medicine.

The efficient delivery of personalized medicine is a key goal of healthcare over the next decade. It is likely that PCR strategies will play an important role in the delivery of this goal. Digital PCR has certain advantages over more traditional PCR protocols. In this article we will discuss the current status of digital PCR, highlighting its advantages and focusing on how it can be utilized in biomarker development and analysis, including the use of individualized biomarkers. We will explore recent developments in this field including examples of how digital PCR may integrate with next generation sequencing to deliver truly personalized medicine.

[1]  S. Kingsmore,et al.  Comprehensive human genome amplification using multiple displacement amplification , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Redon,et al.  Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes , 2007, Science.

[3]  P. George,et al.  Microdissection molecular copy‐number counting (µMCC)—unlocking cancer archives with digital PCR , 2008, The Journal of pathology.

[4]  Alexandra S. Whale,et al.  Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation , 2012, Nucleic acids research.

[5]  J. Radich,et al.  Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCR , 2009, Leukemia.

[6]  Klaus Pantel,et al.  Cell-free nucleic acids as biomarkers in cancer patients , 2011, Nature Reviews Cancer.

[7]  A. Kohlmann,et al.  Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance , 2011, Leukemia.

[8]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[9]  K. Anderson,et al.  Genetic variegation of clonal architecture and propagating cells in leukaemia , 2011, Nature.

[10]  Sung-Liang Yu,et al.  Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Ramesh Ramakrishnan,et al.  Mathematical Analysis of Copy Number Variation in a DNA Sample Using Digital PCR on a Nanofluidic Device , 2008, PloS one.

[12]  Richard M Weinshilboum,et al.  Genomics and drug response. , 2011, The New England journal of medicine.

[13]  Ramesh Ramakrishnan,et al.  Studying copy number variations using a nanofluidic platform , 2008, Nucleic acids research.

[14]  Bruce K Gale,et al.  Spinning disk platform for microfluidic digital polymerase chain reaction. , 2010, Analytical chemistry.

[15]  A. Näär,et al.  MicroRNAs in metabolism and metabolic disorders , 2012, Nature Reviews Molecular Cell Biology.

[16]  Howard Y. Chang,et al.  Epigenomics , 2009, Genomic Medicine.

[17]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[18]  Antony V. Cox,et al.  Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing , 2008, Nature Genetics.

[19]  P. Dear,et al.  Genomic evidence of pre-invasive clonal expansion, dispersal and progression in bronchial dysplasia , 2011, The Journal of pathology.

[20]  Christine P. Tan,et al.  S-1 Supporting Information : Single Molecule Epigenetic Analysis in a Nanofluidic Channel , 2009 .

[21]  S. Quake,et al.  Universal noninvasive detection of solid organ transplant rejection , 2011, Proceedings of the National Academy of Sciences.

[22]  Benjamin J. Hindson,et al.  Evaluation of a Droplet Digital Polymerase Chain Reaction Format for DNA Copy Number Quantification , 2011, Analytical chemistry.

[23]  Yama W. L. Zheng,et al.  Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study , 2011, BMJ : British Medical Journal.

[24]  Nobuyoshi Shimizu,et al.  Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer. , 2006, Cancer research.

[25]  Peter A. Jones,et al.  A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.

[26]  Jim F Huggett,et al.  Evaluation of digital PCR for absolute DNA quantification. , 2011, Analytical chemistry.

[27]  A. Chadli.  THE CANCER CELL , 1924, La Presse medicale.

[28]  A. Ashworth,et al.  Array CGH using whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNA. , 2006, Genomics.

[29]  Thomas Mikeska,et al.  The implications of heterogeneous DNA methylation for the accurate quantification of methylation. , 2010, Epigenomics.

[30]  Simona Soverini,et al.  Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. , 2006, Blood.

[31]  Frank Diehl,et al.  BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions , 2006, Nature Methods.

[32]  Rustem F Ismagilov,et al.  Digital PCR on a SlipChip. , 2010, Lab on a chip.

[33]  김삼묘,et al.  “Bioinformatics” 특집을 내면서 , 2000 .

[34]  Luca Toschi,et al.  Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC. , 2010, Cancer cell.

[35]  T. Rabbitts,et al.  Interrogation of genomes by molecular copy-number counting (MCC) , 2006, Nature Methods.

[36]  David N Louis,et al.  Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine , 2010, EMBO molecular medicine.

[37]  Sabine Tejpar,et al.  Implications for KRAS status and EGFR-targeted therapies in metastatic CRC , 2009, Nature Reviews Clinical Oncology.

[38]  Philippe Corbisier,et al.  Single molecule detection in nanofluidic digital array enables accurate measurement of DNA copy number , 2009, Analytical and bioanalytical chemistry.

[39]  L. Mazutis,et al.  Quantitative and sensitive detection of rare mutations using droplet-based microfluidics. , 2011, Lab on a chip.

[40]  S H Neoh,et al.  Quantitation of targets for PCR by use of limiting dilution. , 1992, BioTechniques.

[41]  K. Kinzler,et al.  Digital PCR. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  T. Mok,et al.  Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non–Small Cell Lung Cancer Patients , 2009, Clinical Cancer Research.

[43]  Hidenori Ojima,et al.  High-resolution characterization of a hepatocellular carcinoma genome , 2011, Nature Genetics.

[44]  Paul H Dear,et al.  Single‐molecule genomics , 2010, The Journal of pathology.

[45]  Ramesh Ramakrishnan,et al.  Taking qPCR to a higher level: Analysis of CNV reveals the power of high throughput qPCR to enhance quantitative resolution. , 2010, Methods.

[46]  J. Troge,et al.  Inferring tumor progression from genomic heterogeneity. , 2010, Genome research.

[47]  Anupam Singhal,et al.  Megapixel digital PCR , 2011, Nature Methods.

[48]  A. Barrett,et al.  Implementing Prenatal Diagnosis Based on Cell-Free Fetal DNA: Accurate Identification of Factors Affecting Fetal DNA Yield , 2011, PloS one.

[49]  Francisco M. De La Vega,et al.  Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing , 2010, Science Translational Medicine.

[50]  Stephen R Quake,et al.  Digital PCR provides sensitive and absolute calibration for high throughput sequencing , 2008, BMC Genomics.

[51]  C. Sawyers,et al.  Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. , 2001, The New England journal of medicine.

[52]  David Bryder,et al.  Transcription factor profiling in individual hematopoietic progenitors by digital RT-PCR , 2006, Proceedings of the National Academy of Sciences.

[53]  Bill W Colston,et al.  High-throughput quantitative polymerase chain reaction in picoliter droplets. , 2008, Analytical chemistry.

[54]  Marius Wernig,et al.  Comprehensive qPCR profiling of gene expression in single neuronal cells , 2011, Nature Protocols.

[55]  John P A Ioannidis,et al.  Clinical outcome prediction by microRNAs in human cancer: a systematic review. , 2012, Journal of the National Cancer Institute.

[56]  J. M. Oshorn.  Proc. Nat. Acad. Sei , 1978 .

[57]  Jason Li,et al.  CONTRA: copy number analysis for targeted resequencing , 2012, Bioinform..

[58]  Ramesh Ramakrishnan,et al.  Quantifying EGFR alterations in the lung cancer genome with nanofluidic digital PCR arrays. , 2010, Clinical chemistry.

[59]  Charles Lee,et al.  Copy number variants and pharmacogenomics. , 2006, Pharmacogenomics.

[60]  Peter R. Cook,et al.  Happy mapping: linkage mapping using a physical analogue of meiosis , 1993, Nucleic Acids Res..

[61]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[62]  Frank Diehl,et al.  BEAMing up for detection and quantification of rare sequence variants , 2006, Nature Methods.

[63]  Tak Y. Leung,et al.  Digital PCR for the molecular detection of fetal chromosomal aneuploidy , 2007, Proceedings of the National Academy of Sciences.

[64]  Giuseppe Saglio,et al.  Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay , 2011, Leukemia & lymphoma.

[65]  V. Beneš,et al.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. , 2009, Clinical chemistry.

[66]  G. Giaccone,et al.  Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  Jeff Mellen,et al.  High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number , 2011, Analytical chemistry.

[68]  Ie-Ming Shih,et al.  Principle and applications of digital PCR , 2004, Expert review of molecular diagnostics.

[69]  Kerry R Emslie,et al.  Effect of sustained elevated temperature prior to amplification on template copy number estimation using digital polymerase chain reaction. , 2011, The Analyst.

[70]  T. Rabbitts,et al.  Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer. , 2010, American journal of respiratory and critical care medicine.

[71]  Allen D. Delaney,et al.  Comprehensive microRNA expression profiling of the hematopoietic hierarchy , 2010, Proceedings of the National Academy of Sciences.

[72]  R. Quatrano.  Genomics , 1998, Plant Cell.